Human Papillomavirus Vaccination and Human Papillomavirus-Associated Cancer Rates Within Florida Counties

被引:7
|
作者
Staras, Stephanie A. S. [1 ,2 ]
Huo, Tianyao [1 ]
Rothbard, Sarah M. [1 ]
Hall, Jaclyn M. [1 ,2 ]
Cho, Hee D. [1 ]
Guo, Yi [1 ]
Richardson, Eric [1 ]
Salloum, Ramzi G. [1 ,2 ]
Thompson, Lindsay A. [1 ,2 ,3 ]
Silver, Natalie L. [4 ]
Shenkman, Elizabeth A. [1 ,2 ]
机构
[1] Univ Florida, Coll Med, UF Dept Hlth Outcomes & Biomed Informat, 2004 Mowry Rd,Room 2238, Gainesville, FL 32610 USA
[2] Univ Florida, UF Inst Child Hlth Policy, Gainesville, FL USA
[3] Univ Florida, Coll Med, Dept Pediat, Gainesville, FL USA
[4] Univ Florida, Coll Med, UF Dept Otolaryngol, Gainesville, FL USA
关键词
AGED; 13-17; YEARS; UNITED-STATES; ADVISORY-COMMITTEE; COVERAGE; TRENDS; RECOMMENDATIONS; MULTILEVEL; MORTALITY; BURDEN; RISK;
D O I
10.1016/j.amepre.2021.05.016
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Introduction: To direct interventions, the Florida counties with the greatest risk of current and future human papillomavirus-associated cancers were identified by estimating county level (1) percentages of adolescents aged 13-17 years who initiated (>= 1 dose) and were up to date (2-3 doses) for the human papillomavirus vaccine and (2) human papillomavirus-associ-ated cancer incidence rates. Methods: Records were obtained for human papillomavirus vaccinations from the Florida immunization registry (2006-2019), incident cancer cases from the Florida registry (2013-2017), and annual population counts from the Florida Department of Health (2006-2019). In 2020, annual county-level human papillomavirus vaccine initiation, human papillomavirus vaccine up-to-date, and age-adjusted human papillomavirus-associated cancer incidence rates were estimated. Results: Among adolescents aged 13-17 years, average 2018-2019 county-specific human papillomavirus vaccine initiation ranged from 38% to 100% for females and from 34% to 96% for males. Up-to-date estimates ranged from 20% to 72% for females and from 24% to 77% for males. The majority (78%) of counties with initiation and up-to-date estimates within the lowest tercile were located in Northern Florida. County-specific 2013-2017 annualized, adjusted human papillomavirus-associated cancer incidence rates ranged from 0 to 29.8 per 100,000 among females and from 5.4 to 24.1 per 100,000 among males. Counties within the highest tercile for human papillomavirus-associated cancers were primarily (90% for females and 77% for males) located in Northern Florida. Conclusions: Human papillomavirus-associated cancer risk varies widely across Florida counties, with particularly high risk within Northern Florida. Targeting interventions toward counties with low vaccination and high cancer rates may reduce human papillomavirus-associated cancers. (C) 2021 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:812 / 820
页数:9
相关论文
共 50 条
  • [31] Considerations in Human Papillomavirus-Associated Oropharyngeal Cancer Screening A Review
    Day, Andrew T.
    Fakhry, Carole
    Tiro, Jasmin A.
    Dahlstrom, Kristina R.
    Sturgis, Erich M.
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2020, 146 (07) : 656 - 664
  • [32] Predictors of distant metastasis in human papillomavirus-associated oropharyngeal cancer
    Weller, Michael A.
    Ward, Matthew C.
    Berriochoa, Camille
    Reddy, Chandana A.
    Trosman, Samuel
    Greskovich, John F.
    Nwizu, Tobenna I.
    Burkey, Brian B.
    Adelstein, David J.
    Koyfman, Shlomo A.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2017, 39 (05): : 940 - 946
  • [33] Human Papillomavirus-Associated Oropharyngeal Cancer: Patterns of Nodal Disease
    Plonowska, Karolina A.
    Strohl, Madeleine P.
    Wang, Steven J.
    Ha, Patrick K.
    George, Jonathan R.
    Heaton, Chase M.
    El-Sayed, Ivan H.
    Mallen-St Clair, Jon
    Ryan, William R.
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2019, 160 (03) : 502 - 509
  • [34] Human papillomavirus, cancer and vaccination
    Heard, Isabelle
    CURRENT OPINION IN HIV AND AIDS, 2011, 6 (04) : 297 - 302
  • [35] Variations in Human Papillomavirus Vaccination and Human Papillomavirus-Related Cancer Rates in Texas, United States
    Adekanmbi, Victor
    Sokale, Itunu
    Guo, Fangjian
    Ngo, Jessica
    Hoang, Thao N.
    Hsu, Christine D.
    Oluyomi, Abiodun
    Berenson, Abbey B.
    JOURNAL OF WOMENS HEALTH, 2024, 33 (09) : A7 - A8
  • [36] Rates of human papillomavirus vaccination, attitudes about vaccination, and human papillomavirus prevalence in young women
    Kahn, Jessica A.
    Rosenthal, Susan L.
    Jin, Yan
    Huang, Bin
    Namakydoust, Azadeh
    Zimet, Gregory D.
    OBSTETRICS AND GYNECOLOGY, 2008, 111 (05): : 1103 - 1110
  • [37] Role of microRNAs in human papillomavirus-associated cancers
    Khan, S.
    Gardiner, A.
    Martinez, I.
    Boster, A.
    Ferris, R.
    Edwards, R.
    FEBS JOURNAL, 2008, 275 : 153 - 153
  • [38] Therapeutic Strategies for Human Papillomavirus-associated Cancers
    Munger, Karl
    JOURNAL OF IMMUNOTHERAPY, 2009, 32 (09) : 1012 - 1012
  • [39] Human papillomavirus-associated tumors of the skin and mucosa
    Majewski, S
    Jablonska, S
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1997, 36 (05) : 659 - 685
  • [40] Pathogenesis of human papillomavirus-associated mucosal disease
    Groves, Ian J.
    Coleman, Nicholas
    JOURNAL OF PATHOLOGY, 2015, 235 (04): : 527 - 538